Teva Pharmaceutical Industries (TEVA) FCF Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | 427.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 410.00 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -2,205.00 |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | -1,494.00 |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn | 1,328.00 |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -5,838.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -1,382.00 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 889.00 |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 427.00 |
| Mar 31, 2026 | 74.00 |
| Dec 31, 2025 | 619.00 |
| Sep 30, 2025 | -738.00 |
| Jun 30, 2025 | 299.00 |
| Mar 31, 2025 | 53.00 |
| Dec 31, 2024 | -852.00 |
| Sep 30, 2024 | 1,632.00 |
| Jun 30, 2024 | -514.00 |
| Mar 31, 2024 | 126.00 |
| Dec 31, 2023 | 250.00 |
| Sep 30, 2023 | -1,545.00 |
| Jun 30, 2023 | 539.00 |
| Mar 31, 2023 | -213.00 |
| Dec 31, 2022 | 1,401.00 |
| Sep 30, 2022 | 186.00 |
| Jun 30, 2022 | -279.00 |
| Mar 31, 2022 | 831.00 |
| Dec 31, 2021 | 391.00 |
| Sep 30, 2021 | 573.00 |